Page last updated: 2024-08-21

6-aminoquinoline and Cytomegalovirus Infections

6-aminoquinoline has been researched along with Cytomegalovirus Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cecchetti, V; Gatto, B; Gribaudo, G; Loregian, A; Massari, S; Mercorelli, B; Muratore, G; Pagni, S; Palù, G; Palumbo, M; Sinigalia, E; Tabarrini, O	1

Other Studies

1 other study(ies) available for 6-aminoquinoline and Cytomegalovirus Infections

Article	Year
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Aminoquinolines; Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; Drug Synergism; Fibroblasts; Gene Expression Regulation, Viral; Humans; Immediate-Early Proteins; Trans-Activators; Transcription, Genetic; Virus Replication	2010

Article

Year

The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein.

Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

Topics: Aminoquinolines; Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; Drug Synergism; Fibroblasts; Gene Expression Regulation, Viral; Humans; Immediate-Early Proteins; Trans-Activators; Transcription, Genetic; Virus Replication

2010